ANIP compared with KNSA: revenue, margins and what each company keeps, and the suppliers and customers both name

ANIPANI Pharmaceuticals Inc

Mkt capRevenueRevenue

KNSAKiniksa Pharmaceuticals International, plc

Mkt capRevenueRevenue

Compare

ANIPANI Pharmaceuticals Inc

KNSAKiniksa Pharmaceuticals International, plc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ANIP

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±8.4%▼−5.30%×0.63

May 8 '26±8.2%▼−2.44%×0.29

Q1 FY26±11.5%▼−4.21%×0.37

Jan 13 '26±5.0%▼−2.45%×0.50

KNSA2 of 4 reports

1 of 1at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±13.9%▲+22.23%×1.60

Q2 FY26—▲+25.03%—

= impliedANIP realized, solidKNSA realized, hatchedOne scale, both sides: full bar = 26%× = |realized| ÷ impliedspan: ANIP 206d · KNSA 91dSource: market data

ANIPANI Pharmaceuticals Inc

71.88▼−0.17%· post 70.69

Mkt cap$1.6BRevenue$266MQ2 FY26Revenue$883MFY25

KNSAKiniksa Pharmaceuticals International, plc

90.92▼−1.43%· post 92.39

ClosedNov 2 '26

Mkt cap$7.2BRevenue$286MQ3 FY26Revenue$678MFY25

Compare

ClosedNov 2 '26

ANIPANI Pharmaceuticals Inc

KNSAKiniksa Pharmaceuticals International, plc

71.88▼−0.17%post 70.69

Price

90.92▼−1.43%post 92.39

$1.6B

Mkt cap

$7.2B

Q2 FY26$266M

Revenue

$286MQ3 FY26

FY25$883M

Revenue

$678MFY25

ANIP71.88▼−0.17%vsKNSA90.92▼−1.43%ClosedNov 2 '26